Sengupta, S., Nandhu, M., Longo, S., Sengupta, S., Longo, J., Sampath, P., & Viapiano, M. (2018). IMMU-39. FIRST-IN-KIND T CELLS CARRYING A CHIMERIC ANTIGEN RECEPTOR AGAINST AN EXTRACELLULAR MATRIX PROTEIN TARGET GLIOBLASTOMA CELLS AND SHOW ANTI-TUMOR EFFICACY. Neuro Oncol.
Citação norma ChicagoSengupta, Sadhak, Mohan Nandhu, Sharon Longo, Sudarshana Sengupta, John Longo, Prakash Sampath, and Mariano Viapiano. "IMMU-39. FIRST-IN-KIND T CELLS CARRYING A CHIMERIC ANTIGEN RECEPTOR AGAINST AN EXTRACELLULAR MATRIX PROTEIN TARGET GLIOBLASTOMA CELLS AND SHOW ANTI-TUMOR EFFICACY." Neuro Oncol 2018.
MLA citiranjeSengupta, Sadhak, et al. "IMMU-39. FIRST-IN-KIND T CELLS CARRYING A CHIMERIC ANTIGEN RECEPTOR AGAINST AN EXTRACELLULAR MATRIX PROTEIN TARGET GLIOBLASTOMA CELLS AND SHOW ANTI-TUMOR EFFICACY." Neuro Oncol 2018.